Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2023-12-29 | New | $3,779,232 | $3,779,232 | Equity Only | 06b | SEC link |
| 2020-06-16 | New | $7,495,040 | $7,495,040 | Equity Only | 06b | SEC link |
| 2018-06-11 | New | $2,237,490 | $2,237,490 | Equity Only | 06b | SEC link |
| 2016-08-11 | New | $6,236,068 | $6,236,068 | Equity Only | 06b | SEC link |
| 2014-07-01 | New | $4,127,158 | $4,127,158 | Equity Only | 06b | SEC link |
| 2012-06-07 | New | $6,200,000 | $6,200,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Connie Curran | Director |
| Carmine J Durham | Director, Executive |
| Alexander M Kasper | Director, Executive |
| Gary J Lehman | Director |
| Michael J. Liang | Director |
| R Andrew Morgan | Executive |
| Roy Andrew Morgan | Executive |
| Andrew Morgan | Executive |
| Frederick A. Robertson | Director |
| Robert Truitt | Director |